VR
IBB icon

Vision Retirement’s iShares Biotechnology ETF IBB Stock Holding History

Vision Retirement’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Hold
100
– – ﹤0.01% 351
2026
Q1 		$16.9K Hold
100
– – ﹤0.01% 350
2025
Q4 		$16.9K Buy
+100
New +$16.2K ﹤0.01% 350

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vision Retirement's IBB Position: Q2 2026 in Review

Vision Retirement held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 100 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Vision Retirement first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. 926 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Vision Retirement held 100 shares of iShares Biotechnology ETF worth $19K as of Q2 2026.
  • Vision Retirement left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Vision Retirement's portfolio in Q2 2026, its #351 holding.
  • Vision Retirement first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • 926 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Vision Retirement's 13F filing for Q2 2026, filed 21 Jul 2026.